Natera supports personalized kidney care and drug development through advanced genetic testing and insights. RenasightIQâ„¢ is a robust clinicogenomic database of 170,000+ chronic kidney disease patients enriched with longitudinal clinical and claims data. This powerful platform delivers real-world insights from early investigation to commercialization to accelerate the kidney disease drug development lifecycle.